Common use of Publications and Presentations Clause in Contracts

Publications and Presentations. The Parties acknowledge that scientific lead-time is a key element of the value of the research and development activities under the Collaboration and further agree that scientific publications and presentations must be strictly monitored to prevent any adverse effect from premature publication or disclosure of results of the research or development activities hereunder. At least thirty (30) days prior to submission of any material related to the research or development activities hereunder for publication or presentation, the submitting Party will provide to the receiving Party a draft of such material for its review and comment. The receiving Party will provide any comments to the submitting Party within twenty (20) days of receipt of such materials alerting the submitting Party to the presence of the receiving Party’s Confidential Information or patentable subject matter that requires protection and in each case, specifically identifying such information (“Notice of Objection”). Each Party will reasonably review proposed publications and presentations submitted by the other Party as promptly as possible and will not unreasonably withhold its consent to such publications or presentations that have been submitted for review with less than the required notice period. 5.3.1 In the event the receiving party makes such Notice of Objection, the submitting party shall refrain from disclosing the material until the receiving Party’s Confidential Information, as identified in the Notice of Objection, is removed. Once the receiving Party’s Confidential Information has been removed, the Notice of Objection will be deemed withdrawn and the submitting party shall not be restricted from publishing the material, provided that any objection based on patentable subject matter contained in the material has also been addressed in accordance with the terms of section 5.3.2. 5.3.2 If the Notice of Objection identifies patentable subject matter then the submitting Party will withhold the material from submission for publication or presentation and the Parties shall work together in good faith and, as quickly as possible after receipt of the Notice of Objection, to file patents and take all necessary measures to establish and preserve proprietary rights that may be contained in the material being submitted for publication or presentation as identified in the Notice of Objection. Once the Parties have taken such steps to protect the patentable subject matter, the Notice of Objection will be deemed withdrawn and the submitting party shall not be restricted from publishing the material. In no event, provided the submitting Party is acting in good faith to protect the patentable material, shall a Notice of Objection relating to patentable material delay publication for longer than three (3) months from the date the Notice of Objection was received by the submitting Party.

Publications and Presentations. The Parties acknowledge that scientific lead-time is a key element SC will coordinate the plans of the value Parties regarding planned publication in the Territory of Data or other clinical or pre-clinical results relating to Products into a single schedule that will be shared with the Parties. With respect to publication in any academic journal, authorship of any publication shall be subject to the obligations of confidentiality herein and determined based on the accepted standards used in peer-reviewed, academic journals at the time of the research proposed publication. Notwithstanding the forgoing, each Party recognizes the mutual interest in obtaining valid Patent protection and development activities under the Collaboration in protecting business interests and further agree that scientific publications and presentations must be strictly monitored trade secret information. Consequently, except for disclosures permitted pursuant to prevent Article 12.2, if either Party, its employees or consultants wishes to publish or present to any adverse effect from premature publication or disclosure of Third Party, results of the Development work, or any research results, or development activities hereunderany Data or other clinical information about a Product being Developed or Commercialized pursuant to this Agreement, it shall deliver to the other Party a copy of the proposed written publication or an outline of an oral disclosure as soon as practicable prior to submission for publication or presentation. At least The reviewing Party shall notify the other Party promptly after receipt of such proposed publication whether such draft publication contains (a) Confidential Information of the reviewing Party, or (b) information that if published would have an adverse effect on a Patent or a Party. The reviewing Party shall have the right to (i) propose modifications to the publication or presentation for Patent reasons, trade secret reasons, confidentiality reasons or business reasons or (ii) request a reasonable delay in publication or presentation in order to protect patentable information. If the reviewing Party requests a delay to protect patentable information, the publishing Party shall delay submission or presentation for a period not to exceed thirty (30) days prior to submission of any material related to the research or development activities hereunder for publication or presentation, the submitting Party will provide to the receiving Party a draft of such material for its review and comment. The receiving Party will provide any comments to the submitting Party within twenty (20) days of receipt of such materials alerting the submitting Party to the presence of the receiving enable Patent applications protecting each Party’s Confidential Information or patentable subject matter that requires protection and rights in each case, specifically identifying such information (“Notice of Objection”). Each Party will reasonably review proposed publications and presentations submitted by the other Party as promptly as possible and will not unreasonably withhold its consent to such publications or presentations that have been submitted for review with less than the required notice period. 5.3.1 In the event the receiving party makes such Notice of Objection, the submitting party shall refrain from disclosing the material until the receiving Party’s Confidential Information, as identified in the Notice of Objection, is removed. Once the receiving Party’s Confidential Information has been removed, the Notice of Objection will be deemed withdrawn and the submitting party shall not be restricted from publishing the material, provided that any objection based on patentable subject matter contained in the material has also been addressed filed in accordance with the terms of section 5.3.2. 5.3.2 this Agreement. Upon expiration of such thirty (30) days, the publishing Party shall be free to proceed with the publication or presentation. If the Notice of Objection identifies patentable subject matter then reviewing Party reasonably requests modifications to the submitting Party will withhold the material from submission for publication or presentation and to prevent disclosure of material trade secret or proprietary business information, the Parties publishing Party shall work together in good faith and, as quickly as possible after receipt edit such publication to prevent the disclosure of such information prior to submission of the Notice of Objection, to file patents and take all necessary measures to establish and preserve proprietary rights that may be contained in the material being submitted for publication or presentation as identified in the Notice of Objection. Once the Parties have taken such steps to protect the patentable subject matter, the Notice of Objection will be deemed withdrawn and the submitting party shall not be restricted from publishing the material. In no event, provided the submitting Party is acting in good faith to protect the patentable material, shall a Notice of Objection relating to patentable material delay publication for longer than three (3) months from the date the Notice of Objection was received by the submitting Partypresentation.

Publications and Presentations. The Parties acknowledge that scientific lead-time is a key element JDC will coordinate the plans of the value Parties regarding planned publication in the Territory of Data or other clinical or pre-clinical results relating to Licensed Products into a single schedule that will be shared with the Parties. With respect to publication in any academic journal, authorship of any publication shall be determined based on the accepted standards used in peer-reviewed, academic journals at the time of the research proposed publication. Notwithstanding the forgoing, each Party recognizes the mutual interest in obtaining valid Patent protection and development activities under the Collaboration in protecting business interests and further agree that scientific publications and presentations must be strictly monitored trade secret information. Consequently, except for disclosures permitted pursuant to prevent Section 12.2, if either Party, its employees or consultants wishes to publish or present to any adverse effect from premature publication or disclosure of Third Party, results of the Development work, or any research results, or development activities hereunderany Data or other clinical information about a Licensed Product being Developed or Commercialized pursuant to this Agreement, it shall deliver to the other Party a copy of the proposed written publication or an outline of an oral disclosure as soon as practicable prior to submission for publication or presentation. At least The reviewing Party shall notify the other Party promptly after of receipt of such proposed publication whether such draft publication contains (a) Confidential Information of the reviewing Party, or (b) information that if published would have an adverse effect on a Patent. The reviewing Party shall have the right to (i) propose modifications to the publication or presentation for Patent reasons, trade secret reasons, confidentiality reasons or business reasons or (ii) request a reasonable delay in publication or presentation in order to protect patentable information. If the reviewing Party requests a delay to protect patentable information, the publishing Party shall delay submission or presentation for a period not to exceed thirty (30) days prior to submission of any material related to the research or development activities hereunder for publication or presentation, the submitting Party will provide to the receiving Party a draft of such material for its review and comment. The receiving Party will provide any comments to the submitting Party within twenty (20) days of receipt of such materials alerting the submitting Party to the presence of the receiving enable Patent applications protecting each Party’s Confidential Information or patentable subject matter that requires protection and rights in each case, specifically identifying such information (“Notice of Objection”). Each Party will reasonably review proposed publications and presentations submitted by the other Party as promptly as possible and will not unreasonably withhold its consent to such publications or presentations that have been submitted for review with less than the required notice period. 5.3.1 In the event the receiving party makes such Notice of Objection, the submitting party shall refrain from disclosing the material until the receiving Party’s Confidential Information, as identified in the Notice of Objection, is removed. Once the receiving Party’s Confidential Information has been removed, the Notice of Objection will be deemed withdrawn and the submitting party shall not be restricted from publishing the material, provided that any objection based on patentable subject matter contained in the material has also been addressed filed in accordance with the terms of section 5.3.2. 5.3.2 this Agreement. Upon expiration of such thirty (30) days, the publishing Party shall be free to proceed with the publication or presentation. If the Notice of Objection identifies patentable subject matter then reviewing Party reasonably requests modifications to the submitting Party will withhold the material from submission for publication or presentation and to prevent disclosure of material trade secret or proprietary business information, the Parties publishing Party shall work together in good faith and, as quickly as possible after receipt edit such publication to prevent the disclosure of such information prior to submission of the Notice of Objection, to file patents and take all necessary measures to establish and preserve proprietary rights that may be contained in the material being submitted for publication or presentation as identified in the Notice of Objection. Once the Parties have taken such steps to protect the patentable subject matter, the Notice of Objection will be deemed withdrawn and the submitting party shall not be restricted from publishing the material. In no event, provided the submitting Party is acting in good faith to protect the patentable material, shall a Notice of Objection relating to patentable material delay publication for longer than three (3) months from the date the Notice of Objection was received by the submitting Partypresentation.

Publications and Presentations. The Parties acknowledge that scientific lead-time is a key element SC will coordinate the plans of the value Parties regarding planned publication in the Territory of Data or other clinical or pre-clinical results relating to Products into a single schedule that will be shared with the Parties. With respect to publication in any academic journal, authorship of any publication shall be determined based on the accepted standards used in peer-reviewed, academic journals at the time of the research proposed publication. Notwithstanding the forgoing, each Party recognizes the mutual interest in obtaining valid Patent protection and development activities under the Collaboration in protecting business interests and further agree that scientific publications and presentations must be strictly monitored trade secret information. Consequently, except for disclosures permitted pursuant to prevent Article 12.2, if either Party, its employees or consultants wishes to publish or present to any adverse effect from premature publication or disclosure of Third Party, results of the Development work, or any research results, or development activities hereunderany Data or other clinical information about a Product being Developed or Commercialized pursuant to this Agreement, it shall deliver to the other Party a copy of the proposed written publication or an outline of an oral disclosure as soon as practicable prior to submission for publication or presentation. At least The reviewing Party shall notify the other Party promptly after of receipt of such proposed publication whether such draft publication contains (a) Confidential Information of the reviewing Party, or (b) information that if published would have an adverse effect on a Patent. The reviewing Party shall have the right to (i) propose modifications to the publication or presentation for Patent reasons, trade secret reasons, confidentiality reasons or business reasons or (ii) request a reasonable delay in publication or presentation in order to protect patentable information. If the reviewing Party requests a delay to protect patentable information, the publishing Party shall delay submission or presentation for a period not to exceed thirty (30) days prior to submission of any material related to the research or development activities hereunder for publication or presentation, the submitting Party will provide to the receiving Party a draft of such material for its review and comment. The receiving Party will provide any comments to the submitting Party within twenty (20) days of receipt of such materials alerting the submitting Party to the presence of the receiving enable Patent applications protecting each Party’s Confidential Information or patentable subject matter that requires protection and rights in each case, specifically identifying such information (“Notice of Objection”). Each Party will reasonably review proposed publications and presentations submitted by the other Party as promptly as possible and will not unreasonably withhold its consent to such publications or presentations that have been submitted for review with less than the required notice period. 5.3.1 In the event the receiving party makes such Notice of Objection, the submitting party shall refrain from disclosing the material until the receiving Party’s Confidential Information, as identified in the Notice of Objection, is removed. Once the receiving Party’s Confidential Information has been removed, the Notice of Objection will be deemed withdrawn and the submitting party shall not be restricted from publishing the material, provided that any objection based on patentable subject matter contained in the material has also been addressed filed in accordance with the terms of section 5.3.2. 5.3.2 this Agreement. Upon expiration of such thirty (30) days, the publishing Party shall be free to proceed with the publication or presentation. If the Notice of Objection identifies patentable subject matter then reviewing Party reasonably requests modifications to the submitting Party will withhold the material from submission for publication or presentation and to prevent disclosure of material trade secret or proprietary business information, the Parties publishing Party shall work together in good faith and, as quickly as possible after receipt edit such publication to prevent the disclosure of such information prior to submission of the Notice of Objection, to file patents and take all necessary measures to establish and preserve proprietary rights that may be contained in the material being submitted for publication or presentation as identified in the Notice of Objection. Once the Parties have taken such steps to protect the patentable subject matter, the Notice of Objection will be deemed withdrawn and the submitting party shall not be restricted from publishing the material. In no event, provided the submitting Party is acting in good faith to protect the patentable material, shall a Notice of Objection relating to patentable material delay publication for longer than three (3) months from the date the Notice of Objection was received by the submitting Partypresentation.

Publications and Presentations. The Parties acknowledge that scientific lead-time is a key element SC will coordinate the plans of the value Parties regarding planned publication of Data and results of clinical or pre-clinical studies of the research Product performed by or on behalf of Licensee in the Territory into a single schedule that will be shared with the Parties. With respect to publication in any academic journal, authorship of any publication shall be determined based on the accepted standards used in peer-reviewed, academic journals at the time of the proposed publication. Notwithstanding the forgoing, each Party recognizes the mutual interest in obtaining valid Patent protection and development activities under the Collaboration in protecting business interests and further agree that scientific publications and presentations must be strictly monitored trade secret information. Consequently, except for disclosures permitted pursuant to prevent Article 12.2, if Licensee, its Affiliates, Designated Parties or their employees or consultants wishes to publish or present to any adverse effect from premature publication or disclosure of Third Party, results of the Development work, or any research results, or development activities hereunder. At any Data or other clinical information about a Product being Developed or Commercialized in the Field in the Territory pursuant to this Agreement, it shall deliver to Licensor a copy of the proposed written publication or an outline of an oral disclosure as soon as practicable and as least thirty (30) days prior to submission of any material related to the research or development activities hereunder for publication or presentation, the submitting Party will provide to the receiving Party a draft of such material for its review and comment. The receiving Party will provide any comments to the submitting Party within twenty (20) days Licensor shall notify Licensee promptly after of receipt of such materials alerting proposed publication whether such draft publication contains (a) Confidential Information of Licensor, or (b) information that if published would have an adverse effect on any Licensor Patent or any Invention. Licensor shall have the submitting Party right to (i) propose modifications to the presence of the receiving Party’s Confidential Information publication or presentation for Patent reasons, trade secret reasons, confidentiality reasons or business reasons or (ii) request a reasonable delay in publication or presentation in order to protect patentable subject matter that requires protection and in each caseinformation. If Licensor requests a delay to protect patentable information, specifically identifying Licensee shall delay submission or presentation for a period not to exceed sixty (60) days to enable Patent applications protecting such information (“Notice of Objection”). Each Party will reasonably review proposed publications and presentations submitted by the other Party as promptly as possible and will not unreasonably withhold its consent to such publications or presentations that have been submitted for review with less than the required notice period. 5.3.1 In the event the receiving party makes such Notice of Objection, the submitting party shall refrain from disclosing the material until the receiving Party’s Confidential Information, as identified in the Notice of Objection, is removed. Once the receiving Party’s Confidential Information has been removed, the Notice of Objection will be deemed withdrawn and the submitting party shall not be restricted from publishing the material, provided that any objection based on patentable subject matter contained in the material has also been addressed filed in accordance with the terms of section 5.3.2. 5.3.2 If this Agreement. In addition, upon Licensor’s request, Licensee shall remove Confidential Information of Licensor prior to submission of the Notice of Objection identifies patentable subject matter then the submitting Party will withhold the material from submission for publication or presentation and the Parties shall work together in good faith and, as quickly as possible after receipt of the Notice of Objection, to file patents and take all necessary measures to establish and preserve proprietary rights that may be contained in the material being submitted for publication or presentation as identified in the Notice of Objection. Once the Parties have taken such steps to protect the patentable subject matter, the Notice of Objection will be deemed withdrawn and the submitting party shall not be restricted from publishing the material. In no event, provided the submitting Party is acting in good faith to protect the patentable material, shall a Notice of Objection relating to patentable material delay publication for longer than three (3) months from the date the Notice of Objection was received by the submitting Partypresentation.